Treatment of HRD-positive ovarian carcinosarcoma: A case report and literature review

Asian J Surg. 2023 Dec;46(12):6047-6048. doi: 10.1016/j.asjsur.2023.09.045. Epub 2023 Sep 22.
No abstract available

Keywords: Gynecologic tumor; HRD-Positive; Malignant mixed mullerian duct tumor; Ovarian cancer sarcoma; PARP inhibitor.

Publication types

  • Review
  • Case Reports
  • Letter

MeSH terms

  • Carcinosarcoma* / surgery
  • Female
  • Humans
  • Ovarian Neoplasms* / surgery